Real-time enrollment status for this blood cancer clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT06492304 |
| Recruiting Status | Recruiting |
| Condition | Blood Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 290 participants |
| Active Locations | 6 sites in the US |
| Sponsor | CRISPR Therapeutics |
| Last Updated on CT.gov | June 29, 2025 (Jun 29, 2025) |
As of March 2, 2026: Clinical trial NCT06492304 is currently recruiting participants. This clinical trial study for blood cancer is actively seeking new participants at 6 locations across the United States. The study is sponsored by CRISPR Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06492304 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06492304 was last updated Jun 29, 2025 (June 29, 2025). HelloStudys verifies this status automatically.